|
Name |
(E,Z)-2,4-Decadienal
|
| Molecular Formula | C10H16O | |
| IUPAC Name* |
(2E,4Z)-deca-2,4-dienal
|
|
| SMILES |
CCCCC/C=C\C=C\C=O
|
|
| InChI |
InChI=1S/C10H16O/c1-2-3-4-5-6-7-8-9-10-11/h6-10H,2-5H2,1H3/b7-6-,9-8+
|
|
| InChIKey |
JZQKTMZYLHNFPL-NMMTYZSQSA-N
|
|
| Synonyms |
(E,Z)-2,4-Decadienal; (2E,4Z)-deca-2,4-dienal; 25152-83-4; 2E,4Z-Decadienal; 2e,4e-decadienal; 2-trans,4-trans-decadienal; (E,E)-2,4-Decanedienal; (E,E)-deca-2,4-dienal; Deca-2(E),4(E)-dienal; (E)-2,(E)-4-decadienal; trans-2,cis-4-Decadienal; 2,4-Decadienal, (E,Z)-; 2,4-Decadienal, (2E,4Z)-; (2E,4Z)-Decadienal; (E,E)-2,4-Decadecenal; Deca-2(E),4(Z)-dienal; SCHEMBL1301734; DTXSID9058739; FEMA 3135; LMFA06000146; ZINC13433325
|
|
| CAS | 25152-83-4 | |
| PubChem CID | 6427087 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 152.23 | ALogp: | 3.2 |
| HBD: | 0 | HBA: | 1 |
| Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 17.1 | Aromatic Rings: | 0 |
| Heavy Atoms: | 11 | QED Weighted: | 0.245 |
| Caco-2 Permeability: | -4.562 | MDCK Permeability: | 0.00002610 |
| Pgp-inhibitor: | 0.007 | Pgp-substrate: | 0.003 |
| Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.005 |
| 30% Bioavailability (F30%): | 0.019 |
| Blood-Brain-Barrier Penetration (BBB): | 0.992 | Plasma Protein Binding (PPB): | 47.64% |
| Volume Distribution (VD): | 1.185 | Fu: | 31.65% |
| CYP1A2-inhibitor: | 0.457 | CYP1A2-substrate: | 0.679 |
| CYP2C19-inhibitor: | 0.095 | CYP2C19-substrate: | 0.769 |
| CYP2C9-inhibitor: | 0.031 | CYP2C9-substrate: | 0.763 |
| CYP2D6-inhibitor: | 0.028 | CYP2D6-substrate: | 0.832 |
| CYP3A4-inhibitor: | 0.05 | CYP3A4-substrate: | 0.212 |
| Clearance (CL): | 5.601 | Half-life (T1/2): | 0.687 |
| hERG Blockers: | 0.037 | Human Hepatotoxicity (H-HT): | 0.414 |
| Drug-inuced Liver Injury (DILI): | 0.015 | AMES Toxicity: | 0.884 |
| Rat Oral Acute Toxicity: | 0.891 | Maximum Recommended Daily Dose: | 0.81 |
| Skin Sensitization: | 0.984 | Carcinogencity: | 0.648 |
| Eye Corrosion: | 0.984 | Eye Irritation: | 0.989 |
| Respiratory Toxicity: | 0.961 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001600 | ![]() |
1.000 | D0UE9X | ![]() |
0.313 | ||
| ENC001724 | ![]() |
0.838 | D01QLH | ![]() |
0.293 | ||
| ENC001597 | ![]() |
0.750 | D0O1TC | ![]() |
0.288 | ||
| ENC001598 | ![]() |
0.686 | D06FEA | ![]() |
0.235 | ||
| ENC001599 | ![]() |
0.632 | D0O1PH | ![]() |
0.228 | ||
| ENC001654 | ![]() |
0.606 | D0N3NO | ![]() |
0.221 | ||
| ENC001601 | ![]() |
0.585 | D0OR6A | ![]() |
0.217 | ||
| ENC001683 | ![]() |
0.472 | D0AY9Q | ![]() |
0.197 | ||
| ENC005508 | ![]() |
0.464 | D09SRR | ![]() |
0.191 | ||
| ENC005507 | ![]() |
0.448 | D0G2MW | ![]() |
0.190 | ||